EPIRUS Biopharmaceuticals, Inc. Convertible Notes Payable, Current
EPIRUS Biopharmaceuticals, Inc. had Convertible Notes Payable, Current of $12.50 million as of 2013-12-31, per its 10-K filed 2015-03-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2015-03-31
- 2013-12-31: Convertible Notes Payable, Current $12.50M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2013-12-31 | $12.50M 10-K · filed 2015-03-31 |